32094 Tirzepatide for Sale
Compare supplier listings for Tirzepatide (CAS 2023788-19-2) — check price, grade and packaging, then open a product page or send an inquiry. View Suppliers
Factory Supply High Purity Tirzepatide 5mg/10mg Weight Loss Peptide 2023788-19-2
-
Price:
$4-5/G FOB
-
CAS No.:
2023788-19-2
-
Grade:
Pharmaceutical Grade
-
Content:
99%
-
Packaging:
15mg*10vials
Top Quality Tirzepatide Lyophilized Powder for Weight Loss & Fitness, CAS 2023788-19-2
-
Price:
$4-5/G FOB
-
CAS No.:
2023788-19-2
-
Grade:
Pharmaceutical Grade
-
Content:
99%
-
Packaging:
15mg*10vials
Tirzepatide Peptide Wholesale Supplier | For Research Only
-
Price:
Price on request
-
CAS No.:
2023788-19-2
-
Grade:
Pharmaceutical Grade
-
Content:
95%
-
Packaging:
10mg/package ,100mg/package
Vitamin K2,NAD+,Semaglutide,Tirzepatide,Sodium Glutathione
Pharma Grade Tirzepatide Peptide | For Research Only
-
Price:
Price on request
-
CAS No.:
2023788-19-2
-
Grade:
Pharmaceutical Grade
-
Content:
95%
-
Packaging:
10mg/package ,100mg/package
Vitamin K2,NAD+,Semaglutide,Tirzepatide,Sodium Glutathione
Tirzepatide Peptide Wholesale | Competitive Price | For Research Only
-
Price:
Price on request
-
CAS No.:
2023788-19-2
-
Grade:
Pharmaceutical Grade
-
Content:
95%
-
Packaging:
10mg/package ,100mg/package
Vitamin K2,NAD+,Semaglutide,Tirzepatide,Sodium Glutathione
Products You May Be Interested in
Bulk Tirzepatide Peptide | Stable Quality | For Research Only
-
Price:
Price on request
-
CAS No.:
2023788-19-2
-
Grade:
Pharmaceutical Grade
-
Content:
95%
-
Packaging:
10mg/package ,100mg/package
Vitamin K2,NAD+,Semaglutide,Tirzepatide,Sodium Glutathione
Tirzepatide Raw Material | Pharmaceutical Grade | Factory Direct Supply FOR RESARCH ONLY
-
Price:
Price on request
-
CAS No.:
2023788-19-2
-
Grade:
Pharmaceutical Grade
-
Content:
95%
-
Packaging:
10mg/package ,100mg/package
Vitamin K2,NAD+,Semaglutide,Tirzepatide,Sodium Glutathione
Tirzepatide CAS 2023788-19-2, 99% Purity, Injectable Grade In Stock
-
Price:
$78-85/G FOB
-
CAS No.:
2023788-19-2
-
Grade:
Pharmaceutical Grade
-
Content:
95%
-
Packaging:
10mg/package ,100mg/package
Vitamin K2,NAD+,Semaglutide,Tirzepatide,Sodium Glutathione
Tirzepatide Powder 99.9% CAS: 2023788-19-2 Peptide
-
Price:
$65-70/G FOB
-
CAS No.:
2023788-19-2
-
Grade:
Pharmaceutical Grade
-
Content:
95%
-
Packaging:
10mg/package ,100mg/package
Vitamin K2,NAD+,Semaglutide,Tirzepatide,Sodium Glutathione
Tirzepatide Raw Ingredient | Laboratory Use | For Research Only
-
Price:
Price on request
-
CAS No.:
2023788-19-2
-
Grade:
Pharmaceutical Grade
-
Content:
95%
-
Packaging:
10mg/package ,100mg/package
Vitamin K2,NAD+,Semaglutide,Tirzepatide,Sodium Glutathione
- If you want to buy Tirzepatide, then ECHEMI will offer you multi-options. ECHEMI emphasizes on verifying suppliers of Tirzepatide who have registered on the platform to ensure the accuracy and reliability of suppliers. Accurate information is the prerequisite of transaction. Find your Tirzepatide order with 70000+ buyers on ECHEMI.
- The quality of Tirzepatide 2023788-19-2 will be secured by ECHEMI. Partners on ECHEMI are all selected in certification, qualification or scale. Tirzepatide will reach global regulation and requirement of various regions. Further services on the whole supply chain can be provided with ECHEMI.
- We offer reasonable and fair market price of Tirzepatide to provide better products and services. Member registered on ECHEMI will enjoy services of Tirzepatide for example market price and insights and trade data. ECHEMI provides the whole supply chain services to with efficient online options. We will help you purchase Tirzepatide and run fast your business.
- •China’s Hybio Takes Generic Tirzepatide to FDA: Lilly’s GLP-1 Fortress Gets a Warning Shot
- •Cipla CEO Calls Tirzepatide a High-Science Product with Strong Market Outlook
- •Novo Nordisk’s Semaglutide Faces Strong Competition: Eli Lilly’s Tirzepatide Officially Launched in China
- •Eli Lilly Revenue Reaches $31.5 Billion, Up 27%! Tirzepatide and Semaglutide Exceed $20 Billion
- •Novo Nordisk's 2024 Earnings Surge by 23%! Diabetes Drug Sales Skyrocket, but Facing Competition Pressure from Tirzepatide